J. Grünfeld, De l'amylose aux amyloses: 1854-1992, MS Médecine Sci, vol.8, issue.6, pp.522-525, 1992.

A. Fleming and V. D. Allison, Observations on a bacteriolytic substance (« lysozyme ») found in secretions and tissues, Br J Exp Pathol, vol.3, issue.5, p.252, 1922.

M. D. Benson, Ostertag revisited: the inherited systemic amyloidoses without neuropathy, Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis, vol.12, issue.2, pp.75-87, 2005.

M. B. Pepys, P. N. Hawkins, D. R. Booth, D. M. Vigushin, G. A. Tennent et al., Human lysozyme gene mutations cause hereditary systemic amyloidosis, Nature, vol.362, issue.6420, pp.553-560, 1993.

J. G. Lanham, M. L. Meltzer, D. Beer, F. C. Hughes, G. R. Pepys et al., Familial amyloidosis of Ostertag, Q J Med, vol.51, pp.25-32, 0201.

M. Yazaki, S. A. Farrell, and M. D. Benson, A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis, Kidney Int, vol.63, issue.5, pp.1652-1659, 2003.

P. T. Sattianayagam, S. Gibbs, D. Rowczenio, J. H. Pinney, and A. D. Wechalekar,

J. A. Gilbertson, Hereditary lysozyme amyloidosis -phenotypic heterogeneity and the role of solid organ transplantation, J Intern Med, vol.272, issue.1, pp.36-44, 2012.

N. Jk, K. Mn, W. Tia, Y. Binan, M. Lagou et al., Amylose rénale héréditaire du lysozyme associée à une mutation W64R (TRY 64 ARG). A propos d'une observation, Rev Afr Médecine Interne, vol.4, issue.1-2, pp.41-46, 2017.

B. Granel, J. Serratrice, S. Valleix, G. Grateau, D. Droz et al., A family with gastrointestinal amyloidosis associated with variant lysozyme, Gastroenterology, vol.123, issue.4, pp.1346-1355, 2002.

B. Granel, J. Serratrice, P. Disdier, P. Weiller, S. Valleix et al.,

, Underdiagnosed amyloidosis: amyloidosis of lysozyme variant, Am J Med, vol.118, issue.3, p.321, 2005.

B. Granel, S. Valleix, J. Serratrice, P. Chérin, A. Texeira et al.,

, Lysozyme amyloidosis: report of 4 cases and a review of the literature, Medicine (Baltimore), vol.85, issue.1, pp.66-73, 2006.

A. Teixeira, G. Grateau, M. Delpech, S. Pelletier, S. Herson et al., Une cause méconnue d'hémopéritoine familial: L'amylose à lysozyme, Rev Médecine Interne, vol.23, p.148, 2002.

E. Jean, S. Valleix, F. Bernard, J. Serratrice, C. Serratrice et al.,

, L'amylose à lysozyme: à propos de cinq familles d'origine piémontaise portant la mutation Trp64Arg, Rev Med Interne, issue.34, pp.79-80, 2013.

A. Benyamine, F. Bernard-guervilly, C. Tummino, N. Macagno, L. Daniel et al.,

S. , Hereditary lysozyme amyloidosis with sicca syndrome, digestive, arterial, and tracheobronchial involvement: case-based review, Clin Rheumatol, vol.36, issue.11, pp.2623-2631, 2017.

E. Jean, L. Benarous, A. Hubert, M. Ebbo, G. Thomas et al., Amylose à lysozyme: description d'une nouvelle famille, Rev Médecine Interne, vol.31, p.115, 2010.

E. Jean, M. Ebbo, S. Valleix, L. Benarous, L. Heyries et al., A new family with hereditary lysozyme amyloidosis with gastritis and inflammatory bowel disease as prevailing symptoms, BMC Gastroenterol, vol.14, p.159, 2014.

B. W. Sperry, A. Dispenzieri, A. Ikram, M. Grogan, J. D. Theis et al.,

, T88N/W130R mutation in the lysozyme gene leading to hereditary lysozyme amyloidosis with biopsy-proven cardiac involvement, Amyloid, vol.24, issue.1, pp.60-61, 2017.

A. M. Zalin, S. Jones, N. J. Fitch, and D. B. Ramsden, Familial nephropathic nonneuropathic amyloidosis: clinical features, immunohistochemistry and chemistry

, Q J Med, vol.81, issue.295, pp.945-56, 1991.

C. Röcken, K. Becker, M. Fändrich, V. Schroeckh, B. Stix et al., ALys amyloidosis caused by compound heterozygosity in exon 2 (Thr70Asn) and exon 4 (Trp112Arg) of the lysozyme gene, Hum Mutat, vol.27, issue.1, pp.119-139, 2006.

G. F. Mells, J. A. Buckels, and D. Thorburn, Emergency liver transplantation for hereditary lysozyme amyloidosis, Liver Transplant, vol.12, issue.12, pp.1908-1917, 2006.

S. Girnius, M. Skinner, B. Spencer, T. Prokaeva, C. Bartholomew et al., A new lysozyme tyr54asn mutation causing amyloidosis in a family of Swedish ancestry with gastrointestinal symptoms, Amyloid, vol.19, issue.4, pp.182-187, 2012.

C. Pleyer, J. Flesche, and F. Saeed, Lysozyme amyloidosis -a case report and review of the literature, Clin Nephrol Case Stud, vol.3, pp.42-47, 2015.

R. F. Harrison, P. N. Hawkins, W. R. Roche, R. F. Macmahon, and S. G. Hubscher,

J. A. , Fragile » liver and massive hepatic haemorrhage due to hereditary amyloidosis, Gut, vol.38, issue.1, pp.151-153, 1996.

M. Loss, W. S. Ng, R. Z. Karim, S. I. Strasser, D. J. Koorey et al.,

, Hereditary lysozyme amyloidosis: spontaneous hepatic rupture (15 years apart) in mother and daughter. role of emergency liver transplantation, Liver Transplant, vol.12, issue.7, pp.1152-1157, 2006.

B. Granel, S. Valleix, L. Treut, Y. Costello, R. Bernard et al.,

C. Sucker, G. R. Hetzel, B. Grabensee, M. Stockschlaeder, and R. E. Scharf,

, Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy, Am J Kidney Dis, vol.47, issue.6, pp.947-55, 2006.

J. D. Gillmore, D. R. Booth, S. Madhoo, M. B. Pepys, and P. N. Hawkins, Hereditary renal amyloidosis associated with variant lysozyme in a large English family, Nephrol Dial Transplant, vol.14, issue.11, pp.2639-2683, 1999.

S. Valleix, S. Drunat, J. Philit, D. Adoue, J. Piette et al., Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family

, Kidney Int, vol.61, issue.3, pp.907-919, 2002.

S. H. Nasr, S. Dasari, J. R. Mills, J. D. Theis, M. T. Zimmermann et al.,

, Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique Phenotype, J Am Soc Nephrol, 2017.

M. A. Khalighi, D. Wallace, W. , and P. Mf, Amyloid nephropathy, Clin Kidney J, vol.7, issue.2, pp.97-106, 2014.

M. Lacy, J. Theis, J. Vrana, S. Madan, L. Frederick et al.,

, Lysozyme amyloidosis (ALys) affecting a family with a new variant of lysozyme gene (LYZ) and hereditary haemorrhagic telangiectasia, Amyloid, vol.17, p.125, 2010.

C. Mccarthy, A. P. Deegan, J. F. Garvey, and T. J. Mcdonnell, Combined pulmonary involvement in hereditary lysozyme amyloidosis with associated pulmonary sarcoidosis: a case report, Sarcoidosis Vasc Diffuse Lung Dis, vol.30, issue.4, pp.321-325, 2013.

C. Wooliver, D. Coriu, C. Murphy, D. Kestler, S. Wang et al., Familial amyloidosis associated with a novel mutation (D68G) in the lysozyme gene, XIth Int Symp Amyloidosis, pp.208-218, 2008.

E. Hachulla and G. Grateau, Diagnostic tools for amyloidosis, Jt Bone Spine Rev Rhum, vol.69, issue.6, pp.538-583, 2002.

N. Magy-bertrand, Actualités sur les amyloses, Rev Médecine Interne, vol.37, issue.8, pp.529-564, 2016.

F. Lavatelli and J. A. Vrana, Proteomic typing of amyloid deposits in systemic amyloidoses, Amyloid, vol.18, issue.4, pp.177-82, 2011.

C. L. Murphy, S. Wang, T. Williams, D. T. Weiss, and A. Solomon, Characterization of systemic amyloid deposits by mass spectrometry, Methods Enzymol, vol.412, pp.48-62, 2006.

M. Ahn, C. L. Hagan, A. Bernardo-gancedo, D. Genst, E. Newby et al.,

J. Christodoulou, The significance of the location of mutations for the nativestate dynamics of human lysozyme, Biophys J, vol.111, issue.11, pp.2358-67, 2016.

M. Ahn, C. A. Waudby, A. Bernardo-gancedo, D. Genst, E. Dhulesia et al.,

X. , Application of Lysine-specific labeling to detect transient interactions present during human Lysozyme Amyloid Fibril formation, Sci Rep, vol.7, issue.1, p.15018, 2017.

D. R. Booth, M. B. Pepys, and P. N. Hawkins, A novel variant of human lysozyme (T70N) is common in the normal population, Hum Mutat, vol.16, issue.2, 2000.

J. Pinney, H. Lachmann, P. Sattianayagam, S. Gibbs, A. Wechalekar et al., Renal transplantation in systemic amyloidosis-importance of amyloid fibril type and precursor protein abundance, Am J Transplant, vol.13, issue.2, pp.433-474, 2013.

M. B. Pepys, J. Herbert, W. L. Hutchinson, G. A. Tennent, H. J. Lachmann et al.,

. Jr, Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis, Nature, vol.417, issue.6886, pp.254-263, 2002.

D. B. Richards, L. M. Cookson, A. C. Berges, S. V. Barton, T. Lane et al.,

, Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

, N Engl J Med, vol.373, issue.12, pp.1106-1120, 2015.

M. Dumoulin, A. M. Last, A. Desmyter, K. Decanniere, D. Canet et al.,

, A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme, Nature, vol.424, issue.6950, pp.783-791, 2003.

P. Chan, E. Pardon, L. Menzer, D. Genst, E. Kumita et al., Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils, Biochemistry (Mosc), vol.47, issue.42, pp.11041-54, 2008.

D. Genst, E. Chan, P. Pardon, E. Hsu, S. Kumita et al., A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation, J Phys Chem B, vol.117, issue.42, pp.13245-58, 2013.

B. Spencer, L. Connors, T. Prokaeva, P. Soohoo, C. O'hara et al., Recent novel and rare mutations in a clinic population of patients with amyloidosis, XIth International Symposium on Amyloidosis, p.20, 2007.